REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

Medicare coverage debates amplify as FDA approves Rexulti for Alzheimer's agitation

Medications for Memory Loss

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

Insights & Implications in Gerontology: Agitation in Alzheimer's Disease by GSAStrategicAlliances - Issuu

Rexulti: Package Insert

agitation that may happen with dementia due to Alzheimer's disease Caregiver Resources

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease

Rexulti: Side effects, dosage, alternatives, and more

Investigation Questions Drug's Approval for Agitation in AD

Psychiatry Alzheimer's Diseasearticles page [1]

FDA OKs First Drug for Agitation in Alzheimer's Dementia

REXULTI®(brexpiprazole)

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients